Behçet's Uveitis.
Behçet's disease is a multisystem inflammatory disorder that is most common in countries along the ancient "Silk Road". The eye is the most commonly involved vital organ in Behçet's patients and the typical form of involvement is a relapsing remitting panuveitis and retinal vasculitis. Uveitis is the initial manifestation of the disease in 10-15% of the patients. Anterior uveitis is always nongranulomatous. Diffuse vitritis, retinal infiltrates, sheathing of predominantly retinal veins, and occlusive vasculitis are the typical signs of posterior segment inflammation. Spontaneous resolution of acute inflammatory signs is a diagnostic feature. Fundus fluorescein angiography is the gold standard in monitoring inflammatory activity. Laser flare photometry is a useful noninvasive tool since flare readings correlate with fluorescein angiographic leakage. The most common complications are cataract, maculopathy, and optic atrophy. Male patients have a more severe disease course and worse visual prognosis. Immunomodulatory therapy is indicated in all patients with posterior segment involvement. Corticosteroids combined with azathioprine and/or cyclosporine is used initially. Biologic agents, including interferon alfa and infliximab, are used in resistant cases. Visual prognosis has improved in recent years with an earlier and more aggressive use of immunomodulatory therapy and the use of biologic agents in resistant cases.
Tugal-Tutkun
Ilknur
I
Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Ocul Immunol Inflamm. 2005 Feb;13(1):51-8
15804770
Jpn J Ophthalmol. 2006 May-Jun;50(3):256-65
16767382
Tissue Antigens. 1999 Sep;54(3):213-20
10519357
Graefes Arch Clin Exp Ophthalmol. 2008 Aug;246(8):1169-77
18504599
Int J Dermatol. 2006 Nov;45(11):1284-7
17076707
Am J Ophthalmol. 2008 Dec;146(6):837-44.e1
19027420
Int Ophthalmol. 2010 Oct;30(5):485-9
18480969
Arthritis Rheum. 2005 Aug;52(8):2478-84
16052571
Ophthalmology. 2008 Feb;115(2):312-318.e4
17692378
Int J Dermatol. 2003 Oct;42(10):803-6
14521694
Int Ophthalmol Clin. 2006 Spring;46(2):209-33
16770164
Ann Rheum Dis. 1984 Dec;43(6):783-9
6524980
Ocul Immunol Inflamm. 2003 Dec;11(4):277-86
14704899
Dev Ophthalmol. 1999;31:118-31
10641204
Rheumatology (Oxford). 2007 May;46(5):736-41
17403712
Ann Rheum Dis. 2007 Apr;66(4):565-6
17124248
Int Ophthalmol. 2005 Jun;26(3):83-92
17031510
Br J Ophthalmol. 2003 Apr;87(4):423-31
12642304
Am J Ophthalmol. 2008 Dec;146(6):845-50.e1
18929351
Brain. 1999 Nov;122 ( Pt 11):2171-82
10545401
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1692-5
16673135
N Engl J Med. 1990 Feb 1;322(5):281-5
2404204
Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):41-6
19294573
Arch Ophthalmol. 1982 Sep;100(9):1455-8
6956266
Rheumatology (Oxford). 2005 Jul;44(7):953-4
15827036
Ophthalmology. 1995 Feb;102(2):317-21
7862420
Rheumatology (Oxford). 2006 Dec;45(12):1461-5
16998234
Br J Ophthalmol. 2007 Dec;91(12):1573-4
18024803
Clin Exp Ophthalmol. 2006 Mar;34(2):188-90
16626443
Medicine (Baltimore). 2003 Jan;82(1):60-76
12544711
Rheumatology (Oxford). 2007 Jul;46(7):1161-4
17478466
Ophthalmology. 1997 Apr;104(4):701-5
9111266
Eye (Lond). 2007 Jun;21(6):824-5
16601736
Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):81-3
15720240
Yonsei Med J. 1999 Jun;40(3):294-6
10412343
Int Ophthalmol. 2009 Jun;29(3):135-41
18365145
Br J Rheumatol. 1992 May;31(5):299-308
1581771
Br J Ophthalmol. 1992 Apr;76(4):241-3
1390495
Am J Ophthalmol. 2003 Dec;136(6):1114-9
14644223
Int Ophthalmol Clin. 2008 Summer;48(3):87-91
18645402
Ann Rheum Dis. 2008 Dec;67(12):1656-62
18245110
Ophthalmology. 2003 Jun;110(6):1137-41
12799237
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350
15967189
Ophthalmology. 2004 Apr;111(4):810-5
15051217
Ann Intern Med. 2004 Mar 2;140(5):404-6
14996689
Lancet. 1989 May 20;1(8647):1093-6
2566048
Nat Clin Pract Rheumatol. 2007 Mar;3(3):148-55
17334337
Am J Ophthalmol. 2004 Sep;138(3):373-80
15364218
Br J Ophthalmol. 2007 Dec;91(12):1579-82
18024808
Lancet. 1990 May 5;335(8697):1078-80
1970380
Am J Ophthalmol. 2008 Dec;146(6):828-36
18708181
J Rheumatol. 2008 May;35(5):896-903
18412306